pyrvinium has been researched along with Cholangiocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarearnrat, A; Kittirat, Y; Klanrit, P; Kulthawatsiri, T; Loilome, W; Mahalapbutr, P; Namwat, N; Phetcharaburanin, J; Promraksa, B; Sangkhamanon, S; Saya, H; Thongchot, S; Wangwiwatsin, A | 1 |
1 other study(ies) available for pyrvinium and Cholangiocarcinoma
| Article | Year |
|---|---|
Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction.
Topics: Adenosine Triphosphate; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Humans; Lipidomics; Lipids; Membrane Potential, Mitochondrial; Pyrvinium Compounds | 2021 |